http://www.fpnotebook.com/
Frontotemporal Dementia
Aka: Frontotemporal Dementia, Pick Disease, Behavioral Variant Frontotemporal Dementia, Semantic Dementia, Progressive Nonfluent Aphasia
- See Also
- Dementia
- Pathophysiology
- Prototype: Pick's Disease
- Tau accumulation in neurons and glia
- Results in atrophy in amygdala and frontal cortex
- Epidemiology
- Accounts for 20-50% of Dementia in age <65 years
- Incidence: 15 per 100,000
- Clinical Findings
- Findings are specific to the Frontotemporal Dementia type
- All types are of insidious onset and gradual progression
- Progressive changes in personality and behavior
- Apathy (e.g. sits and watches television constantly)
- Disinhibition (e.g. tells jokes in bad taste)
- Agitation
- Judgement, reasoning, problem solving difficulty
- Memory may be maintained
- Progressive language Impairment
- Types
- Behavioral Variant Frontotemporal Dementia
- Early decline socially, interpersonally, as well as in conduct, emotional range and insight
- May be associated with distractibility, repetitive behaviors (e.g. Echolalia), and decreased hygiene
- Semantic Dementia
- Effortless speach that lacks meaning
- Uses broad terms instead of detailed specific words
- Failure to recognize familiar faces such as famous people
- Progressive Nonfluent Aphasia
- Nonfluent Aphasia, Stuttering and poor grammar despite significant effort
- Difficult word finding and anomia
- Decreased comprehension
- Lab: Pathology
- Pick bodies (when present FTD is known as Pick Disease)
- Ubiquitin-positive inclusions (55% of Frontotemporal Dementia)
- Associated with TAR DNA-binding protein (TDP-43)
- Associated with progranulin gene mutations
- Associated with Behavioral Variant Frontotemporal Dementia
- Associated with Semantic Dementia
- Tau-positive inclusions (45% of Frontotemporal Dementia)
- Associated with tau gene mutations
- Associated with Behavioral Variant Frontotemporal Dementia
- Associated with Progressive Nonfluent Aphasia
- Management
- Behavioral symptoms
- Consider Selective Serotonin Reuptake Inhibitors (SSRI)
- Aggressive behaviors
- Consider low dose Antipsychotics
- Progressive Nonfluent Aphasia
- Galantamine (Razadyne)
- General Dementia progression
- NMDA Receptor Antagonists (experimental)
- Acetylcholinesterase Inhibitors (experimental)
- Prognosis
- Median survival: 8.7 years
- Contrast with alzheimer's Dementia where survival is 11.8 years
- Semantic Dementia has a median survival closer to alzheimer's Dementia
- Resources
- Association for Frontotemporal Dementia
- http://www.ftd-picks.org
- References
- Cardarelli (2010) Am Fam Physician 82(11): 1372-7
- Josephs (2008) Ann Neurol 64(1): 4-14
- Wittenberg (2008) Neuropsychol Rev 18(1): 91-102